id	sid	tid	token	lemma	pos
cord-265006-m1dmgcd1	1	1	key	key	JJ
cord-265006-m1dmgcd1	2	1	:	:	:
cord-265006-m1dmgcd1	2	2	cord-265006-m1dmgcd1	cord-265006-m1dmgcd1	CD
cord-265006-m1dmgcd1	2	3	authors	author	NNS
cord-265006-m1dmgcd1	2	4	:	:	:
cord-265006-m1dmgcd1	2	5	Kow	Kow	NNP
cord-265006-m1dmgcd1	2	6	,	,	,
cord-265006-m1dmgcd1	2	7	Chia	Chia	NNP
cord-265006-m1dmgcd1	2	8	Siang	Siang	NNP
cord-265006-m1dmgcd1	2	9	;	;	:
cord-265006-m1dmgcd1	2	10	Hasan	Hasan	NNP
cord-265006-m1dmgcd1	2	11	,	,	,
cord-265006-m1dmgcd1	2	12	Syed	Syed	NNP
cord-265006-m1dmgcd1	2	13	Shahzad	Shahzad	NNP
cord-265006-m1dmgcd1	3	1	title	title	NN
cord-265006-m1dmgcd1	3	2	:	:	:
cord-265006-m1dmgcd1	3	3	Do	do	VB
cord-265006-m1dmgcd1	3	4	the	the	DT
cord-265006-m1dmgcd1	3	5	meta	meta	NN
cord-265006-m1dmgcd1	3	6	-	-	HYPH
cord-265006-m1dmgcd1	3	7	analyses	analysis	NNS
cord-265006-m1dmgcd1	3	8	provide	provide	VBP
cord-265006-m1dmgcd1	3	9	a	a	DT
cord-265006-m1dmgcd1	3	10	clean	clean	JJ
cord-265006-m1dmgcd1	3	11	bill	bill	NN
cord-265006-m1dmgcd1	3	12	of	of	IN
cord-265006-m1dmgcd1	3	13	health	health	NN
cord-265006-m1dmgcd1	3	14	to	to	IN
cord-265006-m1dmgcd1	3	15	the	the	DT
cord-265006-m1dmgcd1	3	16	use	use	NN
cord-265006-m1dmgcd1	3	17	of	of	IN
cord-265006-m1dmgcd1	3	18	renin	renin	NN
cord-265006-m1dmgcd1	3	19	-	-	HYPH
cord-265006-m1dmgcd1	3	20	angiotensin	angiotensin	NN
cord-265006-m1dmgcd1	3	21	system	system	NN
cord-265006-m1dmgcd1	3	22	inhibitors	inhibitor	NNS
cord-265006-m1dmgcd1	3	23	in	in	IN
cord-265006-m1dmgcd1	3	24	COVID-19	COVID-19	NNP
cord-265006-m1dmgcd1	3	25	?	?	.
cord-265006-m1dmgcd1	4	1	date	date	NN
cord-265006-m1dmgcd1	4	2	:	:	:
cord-265006-m1dmgcd1	4	3	2020	2020	CD
cord-265006-m1dmgcd1	4	4	-	-	HYPH
cord-265006-m1dmgcd1	4	5	08	08	CD
cord-265006-m1dmgcd1	4	6	-	-	HYPH
cord-265006-m1dmgcd1	4	7	08	08	CD
cord-265006-m1dmgcd1	4	8	journal	journal	NN
cord-265006-m1dmgcd1	4	9	:	:	:
cord-265006-m1dmgcd1	5	1	Clin	Clin	NNP
cord-265006-m1dmgcd1	5	2	Infect	infect	VB
cord-265006-m1dmgcd1	5	3	Dis	Dis	NNP
cord-265006-m1dmgcd1	5	4	DOI	doi	NN
cord-265006-m1dmgcd1	5	5	:	:	:
cord-265006-m1dmgcd1	5	6	10.1093	10.1093	CD
cord-265006-m1dmgcd1	5	7	/	/	SYM
cord-265006-m1dmgcd1	5	8	cid	cid	NN
cord-265006-m1dmgcd1	5	9	/	/	SYM
cord-265006-m1dmgcd1	5	10	ciaa1167	ciaa1167	NNP
cord-265006-m1dmgcd1	5	11	sha	sha	NNP
cord-265006-m1dmgcd1	5	12	:	:	:
cord-265006-m1dmgcd1	5	13	4d52ba37693819e1aed5d587fb77c8eca97530d2	4d52ba37693819e1aed5d587fb77c8eca97530d2	CD
cord-265006-m1dmgcd1	5	14	doc_id	doc_id	CD
cord-265006-m1dmgcd1	5	15	:	:	:
cord-265006-m1dmgcd1	5	16	265006	265006	CD
cord-265006-m1dmgcd1	5	17	cord_uid	cord_uid	NNS
cord-265006-m1dmgcd1	5	18	:	:	:
cord-265006-m1dmgcd1	5	19	m1dmgcd1	m1dmgcd1	.
cord-265006-m1dmgcd1	6	1	nan	nan	NNP
cord-265006-m1dmgcd1	6	2	M	M	NNP
cord-265006-m1dmgcd1	6	3	a	a	NNP
cord-265006-m1dmgcd1	7	1	n	n	CC
cord-265006-m1dmgcd1	7	2	u	u	NNP
cord-265006-m1dmgcd1	7	3	s	s	NNP
cord-265006-m1dmgcd1	7	4	c	c	NN
cord-265006-m1dmgcd1	8	1	r	r	LS
cord-265006-m1dmgcd1	8	2	i	i	NN
cord-265006-m1dmgcd1	8	3	p	p	NN
cord-265006-m1dmgcd1	9	1	t	t	NNP
cord-265006-m1dmgcd1	9	2	Dear	Dear	NNP
cord-265006-m1dmgcd1	9	3	editor	editor	NN
cord-265006-m1dmgcd1	9	4	,	,	,
cord-265006-m1dmgcd1	9	5	We	-PRON-	PRP
cord-265006-m1dmgcd1	9	6	agree	agree	VBP
cord-265006-m1dmgcd1	9	7	with	with	IN
cord-265006-m1dmgcd1	9	8	de	de	NNP
cord-265006-m1dmgcd1	9	9	Feria	Feria	NNP
cord-265006-m1dmgcd1	9	10	et	et	FW
cord-265006-m1dmgcd1	9	11	al	al	NNP
cord-265006-m1dmgcd1	9	12	.	.	.
cord-265006-m1dmgcd1	10	1	[	[	-LRB-
cord-265006-m1dmgcd1	10	2	1	1	CD
cord-265006-m1dmgcd1	10	3	]	]	-RRB-
cord-265006-m1dmgcd1	10	4	which	which	WDT
cord-265006-m1dmgcd1	10	5	commented	comment	VBD
cord-265006-m1dmgcd1	10	6	that	that	IN
cord-265006-m1dmgcd1	10	7	current	current	JJ
cord-265006-m1dmgcd1	10	8	observational	observational	JJ
cord-265006-m1dmgcd1	10	9	studies	study	NNS
cord-265006-m1dmgcd1	10	10	on	on	IN
cord-265006-m1dmgcd1	10	11	the	the	DT
cord-265006-m1dmgcd1	10	12	effects	effect	NNS
cord-265006-m1dmgcd1	10	13	of	of	IN
cord-265006-m1dmgcd1	10	14	renin	renin	NN
cord-265006-m1dmgcd1	10	15	-	-	HYPH
cord-265006-m1dmgcd1	10	16	angiotensin	angiotensin	NN
cord-265006-m1dmgcd1	10	17	system	system	NN
cord-265006-m1dmgcd1	11	1	(	(	-LRB-
cord-265006-m1dmgcd1	11	2	RAS	RAS	NNP
cord-265006-m1dmgcd1	11	3	)	)	-RRB-
cord-265006-m1dmgcd1	11	4	inhibitors	inhibitor	NNS
cord-265006-m1dmgcd1	11	5	use	use	VBP
cord-265006-m1dmgcd1	11	6	in	in	IN
cord-265006-m1dmgcd1	11	7	coronavirus	coronavirus	NN
cord-265006-m1dmgcd1	11	8	disease	disease	NN
cord-265006-m1dmgcd1	11	9	2019	2019	CD
cord-265006-m1dmgcd1	11	10	(	(	-LRB-
cord-265006-m1dmgcd1	11	11	COVID-19	COVID-19	NNP
cord-265006-m1dmgcd1	11	12	)	)	-RRB-
cord-265006-m1dmgcd1	11	13	are	be	VBP
cord-265006-m1dmgcd1	11	14	with	with	IN
cord-265006-m1dmgcd1	11	15	marked	marked	JJ
cord-265006-m1dmgcd1	11	16	limitations	limitation	NNS
cord-265006-m1dmgcd1	11	17	.	.	.
cord-265006-m1dmgcd1	12	1	In	in	IN
cord-265006-m1dmgcd1	12	2	fact	fact	NN
cord-265006-m1dmgcd1	12	3	,	,	,
cord-265006-m1dmgcd1	12	4	we	-PRON-	PRP
cord-265006-m1dmgcd1	12	5	are	be	VBP
cord-265006-m1dmgcd1	12	6	aware	aware	JJ
cord-265006-m1dmgcd1	12	7	of	of	IN
cord-265006-m1dmgcd1	12	8	the	the	DT
cord-265006-m1dmgcd1	12	9	publication	publication	NN
cord-265006-m1dmgcd1	12	10	of	of	IN
cord-265006-m1dmgcd1	12	11	few	few	JJ
cord-265006-m1dmgcd1	12	12	systematic	systematic	JJ
cord-265006-m1dmgcd1	12	13	reviews	review	NNS
cord-265006-m1dmgcd1	12	14	and	and	CC
cord-265006-m1dmgcd1	12	15	metaanalyses	metaanalyse	NNS
cord-265006-m1dmgcd1	12	16	[	[	-LRB-
cord-265006-m1dmgcd1	12	17	2	2	CD
cord-265006-m1dmgcd1	12	18	]	]	-RRB-
cord-265006-m1dmgcd1	12	19	[	[	-LRB-
cord-265006-m1dmgcd1	12	20	3	3	CD
cord-265006-m1dmgcd1	12	21	]	]	-RRB-
cord-265006-m1dmgcd1	12	22	[	[	-LRB-
cord-265006-m1dmgcd1	12	23	4	4	CD
cord-265006-m1dmgcd1	12	24	]	]	-RRB-
cord-265006-m1dmgcd1	12	25	[	[	-LRB-
cord-265006-m1dmgcd1	12	26	5	5	CD
cord-265006-m1dmgcd1	12	27	]	]	-RRB-
cord-265006-m1dmgcd1	12	28	[	[	-LRB-
cord-265006-m1dmgcd1	12	29	6	6	CD
cord-265006-m1dmgcd1	12	30	]	]	-RRB-
cord-265006-m1dmgcd1	12	31	[	[	-LRB-
cord-265006-m1dmgcd1	12	32	7	7	CD
cord-265006-m1dmgcd1	12	33	]	]	-RRB-
cord-265006-m1dmgcd1	12	34	[	[	-LRB-
cord-265006-m1dmgcd1	12	35	8	8	CD
cord-265006-m1dmgcd1	12	36	]	]	-RRB-
cord-265006-m1dmgcd1	12	37	which	which	WDT
cord-265006-m1dmgcd1	12	38	included	include	VBD
cord-265006-m1dmgcd1	12	39	these	these	DT
cord-265006-m1dmgcd1	12	40	observational	observational	JJ
cord-265006-m1dmgcd1	12	41	studies	study	NNS
cord-265006-m1dmgcd1	12	42	with	with	IN
cord-265006-m1dmgcd1	12	43	questionable	questionable	JJ
cord-265006-m1dmgcd1	12	44	quality	quality	NN
cord-265006-m1dmgcd1	12	45	to	to	TO
cord-265006-m1dmgcd1	12	46	determine	determine	VB
cord-265006-m1dmgcd1	12	47	the	the	DT
cord-265006-m1dmgcd1	12	48	association	association	NN
cord-265006-m1dmgcd1	12	49	between	between	IN
cord-265006-m1dmgcd1	12	50	renin	renin	NN
cord-265006-m1dmgcd1	12	51	-	-	HYPH
cord-265006-m1dmgcd1	12	52	angiotensin	angiotensin	NN
cord-265006-m1dmgcd1	12	53	system	system	NN
cord-265006-m1dmgcd1	13	1	(	(	-LRB-
cord-265006-m1dmgcd1	13	2	RAS	RAS	NNP
cord-265006-m1dmgcd1	13	3	)	)	-RRB-
cord-265006-m1dmgcd1	13	4	inhibitors	inhibitor	NNS
cord-265006-m1dmgcd1	13	5	use	use	VBP
cord-265006-m1dmgcd1	13	6	,	,	,
cord-265006-m1dmgcd1	13	7	including	include	VBG
cord-265006-m1dmgcd1	13	8	angiotensin	angiotensin	NN
cord-265006-m1dmgcd1	13	9	converting	convert	VBG
cord-265006-m1dmgcd1	13	10	enzyme	enzyme	NN
cord-265006-m1dmgcd1	13	11	(	(	-LRB-
cord-265006-m1dmgcd1	13	12	ACE	ACE	NNP
cord-265006-m1dmgcd1	13	13	)	)	-RRB-
cord-265006-m1dmgcd1	13	14	inhibitors	inhibitor	NNS
cord-265006-m1dmgcd1	13	15	and	and	CC
cord-265006-m1dmgcd1	13	16	angiotensin	angiotensin	NN
cord-265006-m1dmgcd1	13	17	receptor	receptor	NN
cord-265006-m1dmgcd1	13	18	blockers	blocker	NNS
cord-265006-m1dmgcd1	13	19	(	(	-LRB-
cord-265006-m1dmgcd1	13	20	ARBs	arb	NNS
cord-265006-m1dmgcd1	13	21	)	)	-RRB-
cord-265006-m1dmgcd1	13	22	,	,	,
cord-265006-m1dmgcd1	13	23	and	and	CC
cord-265006-m1dmgcd1	13	24	mortality	mortality	NN
cord-265006-m1dmgcd1	13	25	/	/	SYM
cord-265006-m1dmgcd1	13	26	severity	severity	NN
cord-265006-m1dmgcd1	13	27	of	of	IN
cord-265006-m1dmgcd1	13	28	COVID-19	COVID-19	NNP
cord-265006-m1dmgcd1	13	29	.	.	.
cord-265006-m1dmgcd1	14	1	Therefore	therefore	RB
cord-265006-m1dmgcd1	14	2	,	,	,
cord-265006-m1dmgcd1	14	3	we	-PRON-	PRP
cord-265006-m1dmgcd1	14	4	demand	demand	VBP
cord-265006-m1dmgcd1	14	5	caution	caution	NN
cord-265006-m1dmgcd1	14	6	when	when	WRB
cord-265006-m1dmgcd1	14	7	adopting	adopt	VBG
cord-265006-m1dmgcd1	14	8	the	the	DT
cord-265006-m1dmgcd1	14	9	findings	finding	NNS
cord-265006-m1dmgcd1	14	10	from	from	IN
cord-265006-m1dmgcd1	14	11	these	these	DT
cord-265006-m1dmgcd1	14	12	meta	meta	NNP
cord-265006-m1dmgcd1	14	13	-	-	HYPH
cord-265006-m1dmgcd1	14	14	analyses	analysis	NNS
cord-265006-m1dmgcd1	14	15	.	.	.
cord-265006-m1dmgcd1	15	1	Table	table	NN
cord-265006-m1dmgcd1	15	2	1	1	CD
cord-265006-m1dmgcd1	15	3	summarizes	summarize	VBZ
cord-265006-m1dmgcd1	15	4	the	the	DT
cord-265006-m1dmgcd1	15	5	characteristics	characteristic	NNS
cord-265006-m1dmgcd1	15	6	of	of	IN
cord-265006-m1dmgcd1	15	7	systematic	systematic	JJ
cord-265006-m1dmgcd1	15	8	reviews	review	NNS
cord-265006-m1dmgcd1	15	9	and	and	CC
cord-265006-m1dmgcd1	15	10	meta	meta	NNP
cord-265006-m1dmgcd1	15	11	-	-	HYPH
cord-265006-m1dmgcd1	15	12	analyses	analysis	NNS
cord-265006-m1dmgcd1	15	13	investigating	investigate	VBG
cord-265006-m1dmgcd1	15	14	on	on	IN
cord-265006-m1dmgcd1	15	15	the	the	DT
cord-265006-m1dmgcd1	15	16	use	use	NN
cord-265006-m1dmgcd1	15	17	of	of	IN
cord-265006-m1dmgcd1	15	18	ACEIs	acei	NNS
cord-265006-m1dmgcd1	15	19	/	/	SYM
cord-265006-m1dmgcd1	15	20	ARBs	arb	NNS
cord-265006-m1dmgcd1	15	21	on	on	IN
cord-265006-m1dmgcd1	15	22	COVID-19	covid-19	JJ
cord-265006-m1dmgcd1	15	23	mortality	mortality	NN
cord-265006-m1dmgcd1	15	24	and/or	and/or	CC
cord-265006-m1dmgcd1	15	25	severity	severity	NN
cord-265006-m1dmgcd1	15	26	.	.	.
cord-265006-m1dmgcd1	16	1	Firstly	firstly	RB
cord-265006-m1dmgcd1	16	2	,	,	,
cord-265006-m1dmgcd1	16	3	these	these	DT
cord-265006-m1dmgcd1	16	4	systematic	systematic	JJ
cord-265006-m1dmgcd1	16	5	reviews	review	NNS
cord-265006-m1dmgcd1	16	6	and	and	CC
cord-265006-m1dmgcd1	16	7	meta	meta	NNP
cord-265006-m1dmgcd1	16	8	-	-	HYPH
cord-265006-m1dmgcd1	16	9	analyses	analysis	NNS
cord-265006-m1dmgcd1	16	10	suffer	suffer	VBP
cord-265006-m1dmgcd1	16	11	from	from	IN
cord-265006-m1dmgcd1	16	12	a	a	DT
cord-265006-m1dmgcd1	16	13	common	common	JJ
cord-265006-m1dmgcd1	16	14	methodological	methodological	JJ
cord-265006-m1dmgcd1	16	15	flaw	flaw	NN
cord-265006-m1dmgcd1	16	16	where	where	WRB
cord-265006-m1dmgcd1	16	17	the	the	DT
cord-265006-m1dmgcd1	16	18	authors	author	NNS
cord-265006-m1dmgcd1	16	19	pooled	pool	VBD
cord-265006-m1dmgcd1	16	20	mostly	mostly	RB
cord-265006-m1dmgcd1	16	21	the	the	DT
cord-265006-m1dmgcd1	16	22	unadjusted	unadjusted	JJ
cord-265006-m1dmgcd1	16	23	odds	odd	NNS
cord-265006-m1dmgcd1	16	24	ratio	ratio	NN
cord-265006-m1dmgcd1	16	25	in	in	IN
cord-265006-m1dmgcd1	16	26	their	-PRON-	PRP$
cord-265006-m1dmgcd1	16	27	meta	meta	JJ
cord-265006-m1dmgcd1	16	28	-	-	HYPH
cord-265006-m1dmgcd1	16	29	analyses	analysis	NNS
cord-265006-m1dmgcd1	16	30	to	to	TO
cord-265006-m1dmgcd1	16	31	determine	determine	VB
cord-265006-m1dmgcd1	16	32	the	the	DT
cord-265006-m1dmgcd1	16	33	risk	risk	NN
cord-265006-m1dmgcd1	16	34	of	of	IN
cord-265006-m1dmgcd1	16	35	mortality	mortality	NN
cord-265006-m1dmgcd1	16	36	or	or	CC
cord-265006-m1dmgcd1	16	37	severe	severe	JJ
cord-265006-m1dmgcd1	16	38	/	/	SYM
cord-265006-m1dmgcd1	16	39	critical	critical	JJ
cord-265006-m1dmgcd1	16	40	illness	illness	NN
cord-265006-m1dmgcd1	16	41	from	from	IN
cord-265006-m1dmgcd1	16	42	COVID-19	COVID-19	NNP
cord-265006-m1dmgcd1	16	43	,	,	,
cord-265006-m1dmgcd1	16	44	especially	especially	RB
cord-265006-m1dmgcd1	16	45	when	when	WRB
cord-265006-m1dmgcd1	16	46	the	the	DT
cord-265006-m1dmgcd1	16	47	adjusted	adjust	VBN
cord-265006-m1dmgcd1	16	48	odds	odd	NNS
cord-265006-m1dmgcd1	16	49	ratios	ratio	NNS
cord-265006-m1dmgcd1	16	50	were	be	VBD
cord-265006-m1dmgcd1	16	51	not	not	RB
cord-265006-m1dmgcd1	16	52	provided	provide	VBN
cord-265006-m1dmgcd1	16	53	in	in	IN
cord-265006-m1dmgcd1	16	54	the	the	DT
cord-265006-m1dmgcd1	16	55	included	include	VBN
cord-265006-m1dmgcd1	16	56	original	original	JJ
cord-265006-m1dmgcd1	16	57	studies	study	NNS
cord-265006-m1dmgcd1	16	58	.	.	.
cord-265006-m1dmgcd1	17	1	The	the	DT
cord-265006-m1dmgcd1	17	2	pooling	pooling	NN
cord-265006-m1dmgcd1	17	3	of	of	IN
cord-265006-m1dmgcd1	17	4	unadjusted	unadjusted	JJ
cord-265006-m1dmgcd1	17	5	estimates	estimate	NNS
cord-265006-m1dmgcd1	17	6	can	can	MD
cord-265006-m1dmgcd1	17	7	be	be	VB
cord-265006-m1dmgcd1	17	8	misleading	misleading	JJ
cord-265006-m1dmgcd1	17	9	,	,	,
cord-265006-m1dmgcd1	17	10	since	since	IN
cord-265006-m1dmgcd1	17	11	there	there	EX
cord-265006-m1dmgcd1	17	12	are	be	VBP
cord-265006-m1dmgcd1	17	13	many	many	JJ
cord-265006-m1dmgcd1	17	14	factors	factor	NNS
cord-265006-m1dmgcd1	17	15	that	that	WDT
cord-265006-m1dmgcd1	17	16	could	could	MD
cord-265006-m1dmgcd1	17	17	influence	influence	VB
cord-265006-m1dmgcd1	17	18	the	the	DT
cord-265006-m1dmgcd1	17	19	clinical	clinical	JJ
cord-265006-m1dmgcd1	17	20	outcomes	outcome	NNS
cord-265006-m1dmgcd1	17	21	of	of	IN
cord-265006-m1dmgcd1	17	22	patients	patient	NNS
cord-265006-m1dmgcd1	17	23	with	with	IN
cord-265006-m1dmgcd1	17	24	COVID-19	COVID-19	NNP
cord-265006-m1dmgcd1	17	25	.	.	.
cord-265006-m1dmgcd1	18	1	Without	without	IN
cord-265006-m1dmgcd1	18	2	adjustment	adjustment	NN
cord-265006-m1dmgcd1	18	3	of	of	IN
cord-265006-m1dmgcd1	18	4	the	the	DT
cord-265006-m1dmgcd1	18	5	covariates	covariate	NNS
cord-265006-m1dmgcd1	18	6	or	or	CC
cord-265006-m1dmgcd1	18	7	covariables	covariable	NNS
cord-265006-m1dmgcd1	18	8	which	which	WDT
cord-265006-m1dmgcd1	18	9	could	could	MD
cord-265006-m1dmgcd1	18	10	modify	modify	VB
cord-265006-m1dmgcd1	18	11	the	the	DT
cord-265006-m1dmgcd1	18	12	association	association	NN
cord-265006-m1dmgcd1	18	13	between	between	IN
cord-265006-m1dmgcd1	18	14	RAS	RAS	NNP
cord-265006-m1dmgcd1	18	15	inhibitors	inhibitor	NNS
cord-265006-m1dmgcd1	18	16	use	use	VBP
cord-265006-m1dmgcd1	18	17	and	and	CC
cord-265006-m1dmgcd1	18	18	mortality	mortality	NN
cord-265006-m1dmgcd1	18	19	/	/	SYM
cord-265006-m1dmgcd1	18	20	severity	severity	NN
cord-265006-m1dmgcd1	18	21	of	of	IN
cord-265006-m1dmgcd1	18	22	COVID-19	COVID-19	NNP
cord-265006-m1dmgcd1	18	23	,	,	,
cord-265006-m1dmgcd1	18	24	the	the	DT
cord-265006-m1dmgcd1	18	25	true	true	JJ
cord-265006-m1dmgcd1	18	26	effect	effect	NN
cord-265006-m1dmgcd1	18	27	on	on	IN
cord-265006-m1dmgcd1	18	28	the	the	DT
cord-265006-m1dmgcd1	18	29	use	use	NN
cord-265006-m1dmgcd1	18	30	of	of	IN
cord-265006-m1dmgcd1	18	31	RAS	RAS	NNP
cord-265006-m1dmgcd1	18	32	inhibitors	inhibitor	NNS
cord-265006-m1dmgcd1	18	33	in	in	IN
cord-265006-m1dmgcd1	18	34	COVID-19	COVID-19	NNP
cord-265006-m1dmgcd1	18	35	can	can	MD
cord-265006-m1dmgcd1	18	36	not	not	RB
cord-265006-m1dmgcd1	18	37	be	be	VB
cord-265006-m1dmgcd1	18	38	revealed	reveal	VBN
cord-265006-m1dmgcd1	18	39	even	even	RB
cord-265006-m1dmgcd1	18	40	through	through	IN
cord-265006-m1dmgcd1	18	41	a	a	DT
cord-265006-m1dmgcd1	18	42	meta	meta	JJ
cord-265006-m1dmgcd1	18	43	-	-	HYPH
cord-265006-m1dmgcd1	18	44	analysis	analysis	NN
cord-265006-m1dmgcd1	18	45	.	.	.
cord-265006-m1dmgcd1	19	1	Secondly	secondly	RB
cord-265006-m1dmgcd1	19	2	,	,	,
cord-265006-m1dmgcd1	19	3	some	some	DT
cord-265006-m1dmgcd1	19	4	of	of	IN
cord-265006-m1dmgcd1	19	5	these	these	DT
cord-265006-m1dmgcd1	19	6	systematic	systematic	JJ
cord-265006-m1dmgcd1	19	7	reviews	review	NNS
cord-265006-m1dmgcd1	19	8	and	and	CC
cord-265006-m1dmgcd1	19	9	meta	meta	NNP
cord-265006-m1dmgcd1	19	10	-	-	HYPH
cord-265006-m1dmgcd1	19	11	analyses	analysis	NNS
cord-265006-m1dmgcd1	19	12	included	include	VBD
cord-265006-m1dmgcd1	19	13	studies	study	NNS
cord-265006-m1dmgcd1	19	14	or	or	CC
cord-265006-m1dmgcd1	19	15	only	only	RB
cord-265006-m1dmgcd1	19	16	involved	involve	VBD
cord-265006-m1dmgcd1	19	17	findings	finding	NNS
cord-265006-m1dmgcd1	19	18	on	on	IN
cord-265006-m1dmgcd1	19	19	COVID-19	covid-19	JJ
cord-265006-m1dmgcd1	19	20	patients	patient	NNS
cord-265006-m1dmgcd1	19	21	with	with	IN
cord-265006-m1dmgcd1	19	22	concurrent	concurrent	JJ
cord-265006-m1dmgcd1	19	23	hypertension	hypertension	NN
cord-265006-m1dmgcd1	19	24	.	.	.
cord-265006-m1dmgcd1	20	1	Selective	selective	JJ
cord-265006-m1dmgcd1	20	2	inclusion	inclusion	NN
cord-265006-m1dmgcd1	20	3	of	of	IN
cord-265006-m1dmgcd1	20	4	only	only	JJ
cord-265006-m1dmgcd1	20	5	hypertensive	hypertensive	JJ
cord-265006-m1dmgcd1	20	6	individuals	individual	NNS
cord-265006-m1dmgcd1	20	7	may	may	MD
cord-265006-m1dmgcd1	20	8	not	not	RB
cord-265006-m1dmgcd1	20	9	reflect	reflect	VB
cord-265006-m1dmgcd1	20	10	the	the	DT
cord-265006-m1dmgcd1	20	11	association	association	NN
cord-265006-m1dmgcd1	20	12	between	between	IN
cord-265006-m1dmgcd1	20	13	RAS	RAS	NNP
cord-265006-m1dmgcd1	20	14	inhibitors	inhibitor	NNS
cord-265006-m1dmgcd1	20	15	use	use	VBP
cord-265006-m1dmgcd1	20	16	and	and	CC
cord-265006-m1dmgcd1	20	17	mortality	mortality	NN
cord-265006-m1dmgcd1	20	18	/	/	SYM
cord-265006-m1dmgcd1	20	19	severity	severity	NN
cord-265006-m1dmgcd1	20	20	of	of	IN
cord-265006-m1dmgcd1	20	21	COVID-19	COVID-19	NNP
cord-265006-m1dmgcd1	20	22	since	since	IN
cord-265006-m1dmgcd1	20	23	RAS	RAS	NNP
cord-265006-m1dmgcd1	20	24	inhibitors	inhibitor	NNS
cord-265006-m1dmgcd1	20	25	are	be	VBP
cord-265006-m1dmgcd1	20	26	also	also	RB
cord-265006-m1dmgcd1	20	27	prescribed	prescribe	VBN
cord-265006-m1dmgcd1	20	28	for	for	IN
cord-265006-m1dmgcd1	20	29	indications	indication	NNS
cord-265006-m1dmgcd1	20	30	other	other	JJ
cord-265006-m1dmgcd1	20	31	than	than	IN
cord-265006-m1dmgcd1	20	32	hypertension	hypertension	NN
cord-265006-m1dmgcd1	20	33	,	,	,
cord-265006-m1dmgcd1	20	34	including	include	VBG
cord-265006-m1dmgcd1	20	35	congestive	congestive	JJ
cord-265006-m1dmgcd1	20	36	heart	heart	NN
cord-265006-m1dmgcd1	20	37	failure	failure	NN
cord-265006-m1dmgcd1	20	38	,	,	,
cord-265006-m1dmgcd1	20	39	diabetic	diabetic	JJ
cord-265006-m1dmgcd1	20	40	nephropathy	nephropathy	NN
cord-265006-m1dmgcd1	20	41	,	,	,
cord-265006-m1dmgcd1	20	42	coronary	coronary	JJ
cord-265006-m1dmgcd1	20	43	artery	artery	NN
cord-265006-m1dmgcd1	20	44	disease	disease	NN
cord-265006-m1dmgcd1	20	45	,	,	,
cord-265006-m1dmgcd1	20	46	acute	acute	JJ
cord-265006-m1dmgcd1	20	47	coronary	coronary	JJ
cord-265006-m1dmgcd1	20	48	syndrome	syndrome	NN
cord-265006-m1dmgcd1	20	49	,	,	,
cord-265006-m1dmgcd1	20	50	Raynaud	Raynaud	NNP
cord-265006-m1dmgcd1	20	51	phenomenon	phenomenon	NN
cord-265006-m1dmgcd1	20	52	,	,	,
cord-265006-m1dmgcd1	20	53	amongst	amongst	IN
cord-265006-m1dmgcd1	20	54	others	other	NNS
cord-265006-m1dmgcd1	20	55	.	.	.
cord-265006-m1dmgcd1	21	1	Patients	patient	NNS
cord-265006-m1dmgcd1	21	2	with	with	IN
cord-265006-m1dmgcd1	21	3	these	these	DT
cord-265006-m1dmgcd1	21	4	conditions	condition	NNS
cord-265006-m1dmgcd1	21	5	too	too	RB
cord-265006-m1dmgcd1	21	6	need	need	VBP
cord-265006-m1dmgcd1	21	7	long	long	JJ
cord-265006-m1dmgcd1	21	8	-	-	HYPH
cord-265006-m1dmgcd1	21	9	term	term	NN
cord-265006-m1dmgcd1	21	10	usage	usage	NN
cord-265006-m1dmgcd1	21	11	of	of	IN
cord-265006-m1dmgcd1	21	12	RAS	RAS	NNP
cord-265006-m1dmgcd1	21	13	inhibitors	inhibitor	NNS
cord-265006-m1dmgcd1	21	14	,	,	,
cord-265006-m1dmgcd1	21	15	where	where	WRB
cord-265006-m1dmgcd1	21	16	increased	increase	VBN
cord-265006-m1dmgcd1	21	17	expression	expression	NN
cord-265006-m1dmgcd1	21	18	of	of	IN
cord-265006-m1dmgcd1	21	19	ACE2	ACE2	NNP
cord-265006-m1dmgcd1	21	20	receptor	receptor	NN
cord-265006-m1dmgcd1	21	21	,	,	,
cord-265006-m1dmgcd1	21	22	which	which	WDT
cord-265006-m1dmgcd1	21	23	is	be	VBZ
cord-265006-m1dmgcd1	21	24	the	the	DT
cord-265006-m1dmgcd1	21	25	hypothesized	hypothesize	VBN
cord-265006-m1dmgcd1	21	26	pathological	pathological	JJ
cord-265006-m1dmgcd1	21	27	A	a	NN
cord-265006-m1dmgcd1	21	28	c	c	NN
cord-265006-m1dmgcd1	21	29	c	c	NN
cord-265006-m1dmgcd1	21	30	e	e	NN
cord-265006-m1dmgcd1	21	31	p	p	NN
cord-265006-m1dmgcd1	21	32	t	t	NN
cord-265006-m1dmgcd1	21	33	e	e	NN
cord-265006-m1dmgcd1	21	34	d	d	NNP
cord-265006-m1dmgcd1	21	35	M	M	NNP
cord-265006-m1dmgcd1	21	36	a	a	NNP
cord-265006-m1dmgcd1	21	37	n	n	NN
cord-265006-m1dmgcd1	21	38	u	u	NNP
cord-265006-m1dmgcd1	21	39	s	s	NNP
cord-265006-m1dmgcd1	21	40	c	c	NN
cord-265006-m1dmgcd1	21	41	r	r	NN
cord-265006-m1dmgcd1	21	42	i	i	NN
cord-265006-m1dmgcd1	21	43	p	p	NN
cord-265006-m1dmgcd1	21	44	t	t	NN
cord-265006-m1dmgcd1	21	45	mechanism	mechanism	NN
cord-265006-m1dmgcd1	21	46	leading	lead	VBG
cord-265006-m1dmgcd1	21	47	to	to	IN
cord-265006-m1dmgcd1	21	48	worse	bad	JJR
cord-265006-m1dmgcd1	21	49	outcomes	outcome	NNS
cord-265006-m1dmgcd1	21	50	among	among	IN
cord-265006-m1dmgcd1	21	51	COVID-19	covid-19	JJ
cord-265006-m1dmgcd1	21	52	patients	patient	NNS
cord-265006-m1dmgcd1	21	53	receiving	receive	VBG
cord-265006-m1dmgcd1	21	54	RAS	RAS	NNP
cord-265006-m1dmgcd1	21	55	inhibitors	inhibitor	NNS
cord-265006-m1dmgcd1	21	56	,	,	,
cord-265006-m1dmgcd1	21	57	could	could	MD
cord-265006-m1dmgcd1	21	58	also	also	RB
cord-265006-m1dmgcd1	21	59	occur	occur	VB
cord-265006-m1dmgcd1	21	60	in	in	IN
cord-265006-m1dmgcd1	21	61	the	the	DT
cord-265006-m1dmgcd1	21	62	users	user	NNS
cord-265006-m1dmgcd1	21	63	of	of	IN
cord-265006-m1dmgcd1	21	64	RAS	RAS	NNP
cord-265006-m1dmgcd1	21	65	inhibitors	inhibitor	NNS
cord-265006-m1dmgcd1	21	66	for	for	IN
cord-265006-m1dmgcd1	21	67	indications	indication	NNS
cord-265006-m1dmgcd1	21	68	other	other	JJ
cord-265006-m1dmgcd1	21	69	than	than	IN
cord-265006-m1dmgcd1	21	70	hypertension	hypertension	NN
cord-265006-m1dmgcd1	21	71	[	[	-LRB-
cord-265006-m1dmgcd1	21	72	9	9	CD
cord-265006-m1dmgcd1	21	73	]	]	-RRB-
cord-265006-m1dmgcd1	21	74	.	.	.
cord-265006-m1dmgcd1	22	1	Thirdly	thirdly	RB
cord-265006-m1dmgcd1	22	2	,	,	,
cord-265006-m1dmgcd1	22	3	at	at	IN
cord-265006-m1dmgcd1	22	4	least	least	JJS
cord-265006-m1dmgcd1	22	5	half	half	NN
cord-265006-m1dmgcd1	22	6	of	of	IN
cord-265006-m1dmgcd1	22	7	the	the	DT
cord-265006-m1dmgcd1	22	8	studies	study	NNS
cord-265006-m1dmgcd1	22	9	pooled	pool	VBN
cord-265006-m1dmgcd1	22	10	in	in	IN
cord-265006-m1dmgcd1	22	11	these	these	DT
cord-265006-m1dmgcd1	22	12	systematic	systematic	JJ
cord-265006-m1dmgcd1	22	13	reviews	review	NNS
cord-265006-m1dmgcd1	22	14	and	and	CC
cord-265006-m1dmgcd1	22	15	meta	meta	NNP
cord-265006-m1dmgcd1	22	16	-	-	HYPH
cord-265006-m1dmgcd1	22	17	analyses	analysis	NNS
cord-265006-m1dmgcd1	22	18	(	(	-LRB-
cord-265006-m1dmgcd1	22	19	Table	table	NN
cord-265006-m1dmgcd1	22	20	1	1	CD
cord-265006-m1dmgcd1	22	21	)	)	-RRB-
cord-265006-m1dmgcd1	22	22	are	be	VBP
cord-265006-m1dmgcd1	22	23	originated	originate	VBN
cord-265006-m1dmgcd1	22	24	from	from	IN
cord-265006-m1dmgcd1	22	25	China	China	NNP
cord-265006-m1dmgcd1	22	26	.	.	.
cord-265006-m1dmgcd1	23	1	This	this	DT
cord-265006-m1dmgcd1	23	2	presented	present	VBD
cord-265006-m1dmgcd1	23	3	another	another	DT
cord-265006-m1dmgcd1	23	4	source	source	NN
cord-265006-m1dmgcd1	23	5	of	of	IN
cord-265006-m1dmgcd1	23	6	selection	selection	NN
cord-265006-m1dmgcd1	23	7	bias	bias	NN
cord-265006-m1dmgcd1	23	8	since	since	IN
cord-265006-m1dmgcd1	23	9	patient	patient	JJ
cord-265006-m1dmgcd1	23	10	outcomes	outcome	NNS
cord-265006-m1dmgcd1	23	11	may	may	MD
cord-265006-m1dmgcd1	23	12	be	be	VB
cord-265006-m1dmgcd1	23	13	different	different	JJ
cord-265006-m1dmgcd1	23	14	across	across	IN
cord-265006-m1dmgcd1	23	15	continents	continent	NNS
cord-265006-m1dmgcd1	23	16	or	or	CC
cord-265006-m1dmgcd1	23	17	even	even	RB
cord-265006-m1dmgcd1	23	18	across	across	IN
cord-265006-m1dmgcd1	23	19	different	different	JJ
cord-265006-m1dmgcd1	23	20	countries	country	NNS
cord-265006-m1dmgcd1	23	21	,	,	,
cord-265006-m1dmgcd1	23	22	as	as	IN
cord-265006-m1dmgcd1	23	23	demonstrated	demonstrate	VBN
cord-265006-m1dmgcd1	23	24	in	in	IN
cord-265006-m1dmgcd1	23	25	the	the	DT
cord-265006-m1dmgcd1	23	26	wide	wide	JJ
cord-265006-m1dmgcd1	23	27	interval	interval	NN
cord-265006-m1dmgcd1	23	28	of	of	IN
cord-265006-m1dmgcd1	23	29	case	case	NN
cord-265006-m1dmgcd1	23	30	fatality	fatality	NN
cord-265006-m1dmgcd1	23	31	rates	rate	NNS
cord-265006-m1dmgcd1	23	32	of	of	IN
cord-265006-m1dmgcd1	23	33	COVID-19	covid-19	CD
cord-265006-m1dmgcd1	23	34	among	among	IN
cord-265006-m1dmgcd1	23	35	countries	country	NNS
cord-265006-m1dmgcd1	23	36	.	.	.
cord-265006-m1dmgcd1	24	1	In	in	IN
cord-265006-m1dmgcd1	24	2	fact	fact	NN
cord-265006-m1dmgcd1	24	3	,	,	,
cord-265006-m1dmgcd1	24	4	while	while	IN
cord-265006-m1dmgcd1	24	5	all	all	DT
cord-265006-m1dmgcd1	24	6	studies	study	NNS
cord-265006-m1dmgcd1	24	7	from	from	IN
cord-265006-m1dmgcd1	24	8	China	China	NNP
cord-265006-m1dmgcd1	24	9	reported	report	VBD
cord-265006-m1dmgcd1	24	10	either	either	CC
cord-265006-m1dmgcd1	24	11	no	no	DT
cord-265006-m1dmgcd1	24	12	difference	difference	NN
cord-265006-m1dmgcd1	24	13	or	or	CC
cord-265006-m1dmgcd1	24	14	significant	significant	JJ
cord-265006-m1dmgcd1	24	15	reduced	reduce	VBN
cord-265006-m1dmgcd1	24	16	risk	risk	NN
cord-265006-m1dmgcd1	24	17	of	of	IN
cord-265006-m1dmgcd1	24	18	mortality	mortality	NN
cord-265006-m1dmgcd1	24	19	and/or	and/or	CC
cord-265006-m1dmgcd1	24	20	severe	severe	JJ
cord-265006-m1dmgcd1	24	21	/	/	SYM
cord-265006-m1dmgcd1	24	22	critical	critical	JJ
cord-265006-m1dmgcd1	24	23	disease	disease	NN
cord-265006-m1dmgcd1	24	24	from	from	IN
cord-265006-m1dmgcd1	24	25	COVID-19	COVID-19	NNP
cord-265006-m1dmgcd1	24	26	among	among	IN
cord-265006-m1dmgcd1	24	27	users	user	NNS
cord-265006-m1dmgcd1	24	28	of	of	IN
cord-265006-m1dmgcd1	24	29	ACEIs	acei	NNS
cord-265006-m1dmgcd1	24	30	/	/	SYM
cord-265006-m1dmgcd1	24	31	ARBs	arb	NNS
cord-265006-m1dmgcd1	24	32	compared	compare	VBN
cord-265006-m1dmgcd1	24	33	to	to	IN
cord-265006-m1dmgcd1	24	34	non	non	NNS
cord-265006-m1dmgcd1	24	35	-	-	NNS
cord-265006-m1dmgcd1	24	36	users	user	NNS
cord-265006-m1dmgcd1	24	37	,	,	,
cord-265006-m1dmgcd1	24	38	a	a	DT
cord-265006-m1dmgcd1	24	39	single	single	JJ
cord-265006-m1dmgcd1	24	40	-	-	HYPH
cord-265006-m1dmgcd1	24	41	center	center	NN
cord-265006-m1dmgcd1	24	42	study	study	NN
cord-265006-m1dmgcd1	24	43	[	[	-LRB-
cord-265006-m1dmgcd1	24	44	10	10	CD
cord-265006-m1dmgcd1	24	45	]	]	-RRB-
cord-265006-m1dmgcd1	24	46	from	from	IN
cord-265006-m1dmgcd1	24	47	France	France	NNP
cord-265006-m1dmgcd1	24	48	reported	report	VBD
cord-265006-m1dmgcd1	24	49	otherwise	otherwise	RB
cord-265006-m1dmgcd1	24	50	,	,	,
cord-265006-m1dmgcd1	24	51	in	in	IN
cord-265006-m1dmgcd1	24	52	which	which	WDT
cord-265006-m1dmgcd1	24	53	hospitalized	hospitalize	VBD
cord-265006-m1dmgcd1	24	54	patients	patient	NNS
cord-265006-m1dmgcd1	24	55	with	with	IN
cord-265006-m1dmgcd1	24	56	COVID-19	COVID-19	NNP
cord-265006-m1dmgcd1	24	57	receiving	receive	VBG
cord-265006-m1dmgcd1	24	58	RAS	RAS	NNP
cord-265006-m1dmgcd1	24	59	inhibitors	inhibitor	NNS
cord-265006-m1dmgcd1	24	60	at	at	IN
cord-265006-m1dmgcd1	24	61	baseline	baseline	NN
cord-265006-m1dmgcd1	24	62	had	have	VBD
cord-265006-m1dmgcd1	24	63	significantly	significantly	RB
cord-265006-m1dmgcd1	24	64	increased	increase	VBN
cord-265006-m1dmgcd1	24	65	odds	odd	NNS
cord-265006-m1dmgcd1	24	66	of	of	IN
cord-265006-m1dmgcd1	24	67	being	be	VBG
cord-265006-m1dmgcd1	24	68	admitted	admit	VBN
cord-265006-m1dmgcd1	24	69	to	to	IN
cord-265006-m1dmgcd1	24	70	an	an	DT
cord-265006-m1dmgcd1	24	71	intensive	intensive	JJ
cord-265006-m1dmgcd1	24	72	care	care	NN
cord-265006-m1dmgcd1	24	73	unit	unit	NN
cord-265006-m1dmgcd1	24	74	or	or	CC
cord-265006-m1dmgcd1	24	75	death	death	NN
cord-265006-m1dmgcd1	24	76	before	before	IN
cord-265006-m1dmgcd1	24	77	admission	admission	NN
cord-265006-m1dmgcd1	24	78	to	to	IN
cord-265006-m1dmgcd1	24	79	an	an	DT
cord-265006-m1dmgcd1	24	80	intensive	intensive	JJ
cord-265006-m1dmgcd1	24	81	care	care	NN
cord-265006-m1dmgcd1	24	82	unit	unit	NN
cord-265006-m1dmgcd1	24	83	(	(	-LRB-
cord-265006-m1dmgcd1	24	84	odds	odd	NNS
cord-265006-m1dmgcd1	24	85	ratio	ratio	NN
cord-265006-m1dmgcd1	24	86	1.73	1.73	CD
cord-265006-m1dmgcd1	24	87	,	,	,
cord-265006-m1dmgcd1	24	88	95	95	CD
cord-265006-m1dmgcd1	24	89	%	%	NN
cord-265006-m1dmgcd1	24	90	confidence	confidence	NN
cord-265006-m1dmgcd1	24	91	interval	interval	NN
cord-265006-m1dmgcd1	24	92	1.02	1.02	CD
cord-265006-m1dmgcd1	24	93	-	-	SYM
cord-265006-m1dmgcd1	24	94	2.93	2.93	CD
cord-265006-m1dmgcd1	24	95	)	)	-RRB-
cord-265006-m1dmgcd1	24	96	.	.	.
cord-265006-m1dmgcd1	25	1	Therefore	therefore	RB
cord-265006-m1dmgcd1	25	2	,	,	,
cord-265006-m1dmgcd1	25	3	there	there	EX
cord-265006-m1dmgcd1	25	4	may	may	MD
cord-265006-m1dmgcd1	25	5	be	be	VB
cord-265006-m1dmgcd1	25	6	regional	regional	JJ
cord-265006-m1dmgcd1	25	7	differences	difference	NNS
cord-265006-m1dmgcd1	25	8	in	in	IN
cord-265006-m1dmgcd1	25	9	the	the	DT
cord-265006-m1dmgcd1	25	10	clinical	clinical	JJ
cord-265006-m1dmgcd1	25	11	outcomes	outcome	NNS
cord-265006-m1dmgcd1	25	12	from	from	IN
cord-265006-m1dmgcd1	25	13	COVID-19	COVID-19	NNP
cord-265006-m1dmgcd1	25	14	among	among	IN
cord-265006-m1dmgcd1	25	15	patients	patient	NNS
cord-265006-m1dmgcd1	25	16	receiving	receive	VBG
cord-265006-m1dmgcd1	25	17	ACEIs	acei	NNS
cord-265006-m1dmgcd1	25	18	/	/	SYM
cord-265006-m1dmgcd1	25	19	ARBs	arb	NNS
cord-265006-m1dmgcd1	25	20	which	which	WDT
cord-265006-m1dmgcd1	25	21	the	the	DT
cord-265006-m1dmgcd1	25	22	currently	currently	RB
cord-265006-m1dmgcd1	25	23	available	available	JJ
cord-265006-m1dmgcd1	25	24	systematic	systematic	JJ
cord-265006-m1dmgcd1	25	25	reviews	review	NNS
cord-265006-m1dmgcd1	25	26	and	and	CC
cord-265006-m1dmgcd1	25	27	meta	meta	NNP
cord-265006-m1dmgcd1	25	28	-	-	HYPH
cord-265006-m1dmgcd1	25	29	analysis	analysis	NN
cord-265006-m1dmgcd1	25	30	failed	fail	VBD
cord-265006-m1dmgcd1	25	31	to	to	TO
cord-265006-m1dmgcd1	25	32	address	address	VB
cord-265006-m1dmgcd1	25	33	.	.	.
cord-265006-m1dmgcd1	26	1	We	-PRON-	PRP
cord-265006-m1dmgcd1	26	2	agree	agree	VBP
cord-265006-m1dmgcd1	26	3	with	with	IN
cord-265006-m1dmgcd1	26	4	de	de	NNP
cord-265006-m1dmgcd1	26	5	Feria	Feria	NNP
cord-265006-m1dmgcd1	26	6	et	et	FW
cord-265006-m1dmgcd1	26	7	al	al	NNP
cord-265006-m1dmgcd1	26	8	.	.	.
cord-265006-m1dmgcd1	27	1	[	[	-LRB-
cord-265006-m1dmgcd1	27	2	1	1	LS
cord-265006-m1dmgcd1	27	3	]	]	-RRB-
cord-265006-m1dmgcd1	27	4	that	that	IN
cord-265006-m1dmgcd1	27	5	only	only	RB
cord-265006-m1dmgcd1	27	6	through	through	IN
cord-265006-m1dmgcd1	27	7	randomized	randomized	JJ
cord-265006-m1dmgcd1	27	8	controlled	control	VBN
cord-265006-m1dmgcd1	27	9	trials	trial	NNS
cord-265006-m1dmgcd1	27	10	that	that	WDT
cord-265006-m1dmgcd1	27	11	a	a	DT
cord-265006-m1dmgcd1	27	12	cause	cause	NN
cord-265006-m1dmgcd1	27	13	-	-	HYPH
cord-265006-m1dmgcd1	27	14	andeffect	andeffect	NN
cord-265006-m1dmgcd1	27	15	relationship	relationship	NN
cord-265006-m1dmgcd1	27	16	can	can	MD
cord-265006-m1dmgcd1	27	17	be	be	VB
cord-265006-m1dmgcd1	27	18	established	establish	VBN
cord-265006-m1dmgcd1	27	19	.	.	.
cord-265006-m1dmgcd1	28	1	Nevertheless	nevertheless	RB
cord-265006-m1dmgcd1	28	2	,	,	,
cord-265006-m1dmgcd1	28	3	future	future	JJ
cord-265006-m1dmgcd1	28	4	retrospective	retrospective	JJ
cord-265006-m1dmgcd1	28	5	or	or	CC
cord-265006-m1dmgcd1	28	6	prospective	prospective	JJ
cord-265006-m1dmgcd1	28	7	studies	study	NNS
cord-265006-m1dmgcd1	28	8	should	should	MD
cord-265006-m1dmgcd1	28	9	adjust	adjust	VB
cord-265006-m1dmgcd1	28	10	for	for	IN
cord-265006-m1dmgcd1	28	11	covariates	covariate	NNS
cord-265006-m1dmgcd1	28	12	or	or	CC
cord-265006-m1dmgcd1	28	13	covariables	covariable	NNS
cord-265006-m1dmgcd1	28	14	in	in	IN
cord-265006-m1dmgcd1	28	15	their	-PRON-	PRP$
cord-265006-m1dmgcd1	28	16	analysis	analysis	NN
cord-265006-m1dmgcd1	28	17	to	to	TO
cord-265006-m1dmgcd1	28	18	provide	provide	VB
cord-265006-m1dmgcd1	28	19	more	more	JJR
cord-265006-m1dmgcd1	28	20	clarity	clarity	NN
cord-265006-m1dmgcd1	28	21	on	on	IN
cord-265006-m1dmgcd1	28	22	the	the	DT
cord-265006-m1dmgcd1	28	23	association	association	NN
cord-265006-m1dmgcd1	28	24	between	between	IN
cord-265006-m1dmgcd1	28	25	RAS	RAS	NNP
cord-265006-m1dmgcd1	28	26	inhibitors	inhibitor	NNS
cord-265006-m1dmgcd1	28	27	use	use	VBP
cord-265006-m1dmgcd1	28	28	and	and	CC
cord-265006-m1dmgcd1	28	29	clinical	clinical	JJ
cord-265006-m1dmgcd1	28	30	outcomes	outcome	NNS
cord-265006-m1dmgcd1	28	31	of	of	IN
cord-265006-m1dmgcd1	28	32	COVID-19	covid-19	NN
cord-265006-m1dmgcd1	28	33	.	.	.
cord-265006-m1dmgcd1	29	1	A	a	DT
cord-265006-m1dmgcd1	29	2	c	c	NN
cord-265006-m1dmgcd1	29	3	c	c	NN
cord-265006-m1dmgcd1	29	4	e	e	NN
cord-265006-m1dmgcd1	29	5	p	p	NN
cord-265006-m1dmgcd1	29	6	t	t	NN
cord-265006-m1dmgcd1	29	7	e	e	NN
cord-265006-m1dmgcd1	29	8	d	d	NNP
cord-265006-m1dmgcd1	29	9	M	M	NNP
cord-265006-m1dmgcd1	29	10	a	a	NNP
cord-265006-m1dmgcd1	30	1	n	n	CC
cord-265006-m1dmgcd1	30	2	u	u	NNP
cord-265006-m1dmgcd1	30	3	s	s	NNP
cord-265006-m1dmgcd1	30	4	c	c	NN
cord-265006-m1dmgcd1	30	5	r	r	NN
cord-265006-m1dmgcd1	30	6	i	i	NN
cord-265006-m1dmgcd1	30	7	p	p	NN
cord-265006-m1dmgcd1	30	8	t	t	NN
cord-265006-m1dmgcd1	30	9	M	M	NNP
cord-265006-m1dmgcd1	30	10	a	a	NNP
cord-265006-m1dmgcd1	30	11	n	n	NN
cord-265006-m1dmgcd1	30	12	u	u	NNP
cord-265006-m1dmgcd1	30	13	s	s	NN
cord-265006-m1dmgcd1	30	14	c	c	NN
cord-265006-m1dmgcd1	31	1	r	r	LS
cord-265006-m1dmgcd1	31	2	i	i	PRP
cord-265006-m1dmgcd1	32	1	p	p	NN
cord-265006-m1dmgcd1	32	2	t	t	NNP
cord-265006-m1dmgcd1	32	3	 	 	_SP
cord-265006-m1dmgcd1	33	1	ACE	ACE	NNP
cord-265006-m1dmgcd1	33	2	inhibitors	inhibitor	NNS
cord-265006-m1dmgcd1	33	3	/	/	SYM
cord-265006-m1dmgcd1	33	4	ARB	ARB	NNP
cord-265006-m1dmgcd1	33	5	use	use	NN
cord-265006-m1dmgcd1	33	6	and	and	CC
cord-265006-m1dmgcd1	33	7	COVID-19	covid-19	NN
cord-265006-m1dmgcd1	33	8	.	.	.
cord-265006-m1dmgcd1	34	1	Time	time	NN
cord-265006-m1dmgcd1	34	2	to	to	TO
cord-265006-m1dmgcd1	34	3	change	change	VB
cord-265006-m1dmgcd1	34	4	practice	practice	NN
cord-265006-m1dmgcd1	34	5	or	or	CC
cord-265006-m1dmgcd1	34	6	keep	keep	VB
cord-265006-m1dmgcd1	34	7	gathering	gather	VBG
cord-265006-m1dmgcd1	34	8	data	datum	NNS
cord-265006-m1dmgcd1	34	9	?	?	.
cord-265006-m1dmgcd1	35	1	A	a	DT
cord-265006-m1dmgcd1	35	2	systematic	systematic	JJ
cord-265006-m1dmgcd1	35	3	review	review	NN
cord-265006-m1dmgcd1	35	4	and	and	CC
cord-265006-m1dmgcd1	35	5	meta	meta	NNP
cord-265006-m1dmgcd1	35	6	-	-	HYPH
cord-265006-m1dmgcd1	35	7	analysis	analysis	NN
cord-265006-m1dmgcd1	35	8	to	to	TO
cord-265006-m1dmgcd1	35	9	evaluate	evaluate	VB
cord-265006-m1dmgcd1	35	10	the	the	DT
cord-265006-m1dmgcd1	35	11	clinical	clinical	JJ
cord-265006-m1dmgcd1	35	12	outcomes	outcome	NNS
cord-265006-m1dmgcd1	35	13	in	in	IN
cord-265006-m1dmgcd1	35	14	COVID-19	covid-19	JJ
cord-265006-m1dmgcd1	35	15	patients	patient	NNS
cord-265006-m1dmgcd1	35	16	on	on	IN
cord-265006-m1dmgcd1	35	17	angiotensin	angiotensin	NN
cord-265006-m1dmgcd1	35	18	-	-	HYPH
cord-265006-m1dmgcd1	35	19	converting	convert	VBG
cord-265006-m1dmgcd1	35	20	enzyme	enzyme	NN
cord-265006-m1dmgcd1	35	21	inhibitors	inhibitor	NNS
cord-265006-m1dmgcd1	35	22	or	or	CC
cord-265006-m1dmgcd1	35	23	angiotensin	angiotensin	NN
cord-265006-m1dmgcd1	35	24	receptor	receptor	NN
cord-265006-m1dmgcd1	35	25	blockers	blocker	NNS
cord-265006-m1dmgcd1	35	26	Decreased	decrease	VBD
cord-265006-m1dmgcd1	35	27	Mortality	Mortality	NNP
cord-265006-m1dmgcd1	35	28	of	of	IN
cord-265006-m1dmgcd1	35	29	COVID-19	COVID-19	NNP
cord-265006-m1dmgcd1	35	30	With	with	IN
cord-265006-m1dmgcd1	35	31	Renin	Renin	NNP
cord-265006-m1dmgcd1	35	32	-	-	HYPH
cord-265006-m1dmgcd1	35	33	Angiotensin	Angiotensin	NNP
cord-265006-m1dmgcd1	35	34	-	-	HYPH
cord-265006-m1dmgcd1	35	35	Aldosterone	Aldosterone	NNP
cord-265006-m1dmgcd1	35	36	System	System	NNP
cord-265006-m1dmgcd1	35	37	Inhibitors	Inhibitors	NNP
cord-265006-m1dmgcd1	35	38	Therapy	Therapy	NNP
cord-265006-m1dmgcd1	35	39	in	in	IN
cord-265006-m1dmgcd1	35	40	Patients	patient	NNS
cord-265006-m1dmgcd1	35	41	With	with	IN
cord-265006-m1dmgcd1	35	42	Hypertension	hypertension	NN
cord-265006-m1dmgcd1	35	43	:	:	:
cord-265006-m1dmgcd1	36	1	A	a	DT
cord-265006-m1dmgcd1	36	2	Meta	Meta	NNP
cord-265006-m1dmgcd1	36	3	-	-	HYPH
cord-265006-m1dmgcd1	36	4	Analysis	Analysis	NNP
cord-265006-m1dmgcd1	36	5	Estimation	Estimation	NNP
cord-265006-m1dmgcd1	36	6	of	of	IN
cord-265006-m1dmgcd1	36	7	Renin	Renin	NNP
cord-265006-m1dmgcd1	36	8	-	-	HYPH
cord-265006-m1dmgcd1	36	9	Angiotensin	Angiotensin	NNP
cord-265006-m1dmgcd1	36	10	-	-	HYPH
cord-265006-m1dmgcd1	36	11	Aldosterone	Aldosterone	NNP
cord-265006-m1dmgcd1	36	12	-	-	HYPH
cord-265006-m1dmgcd1	36	13	System	System	NNP
cord-265006-m1dmgcd1	36	14	(	(	-LRB-
cord-265006-m1dmgcd1	36	15	RAAS)-Inhibitor	RAAS)-Inhibitor	NNP
cord-265006-m1dmgcd1	36	16	effect	effect	NN
cord-265006-m1dmgcd1	36	17	on	on	IN
cord-265006-m1dmgcd1	36	18	COVID-19	COVID-19	NNP
cord-265006-m1dmgcd1	36	19	outcome	outcome	NN
cord-265006-m1dmgcd1	36	20	:	:	:
cord-265006-m1dmgcd1	36	21	A	a	DT
cord-265006-m1dmgcd1	36	22	Meta	Meta	NNP
cord-265006-m1dmgcd1	36	23	-	-	HYPH
cord-265006-m1dmgcd1	36	24	analysis	analysis	NN
cord-265006-m1dmgcd1	36	25	ACEI	ACEI	NNP
cord-265006-m1dmgcd1	36	26	/	/	SYM
cord-265006-m1dmgcd1	36	27	ARB	ARB	NNP
cord-265006-m1dmgcd1	36	28	use	use	NN
cord-265006-m1dmgcd1	36	29	and	and	CC
cord-265006-m1dmgcd1	36	30	risk	risk	NN
cord-265006-m1dmgcd1	36	31	of	of	IN
cord-265006-m1dmgcd1	36	32	infection	infection	NN
cord-265006-m1dmgcd1	36	33	or	or	CC
cord-265006-m1dmgcd1	36	34	severity	severity	NN
cord-265006-m1dmgcd1	36	35	or	or	CC
cord-265006-m1dmgcd1	36	36	mortality	mortality	NN
cord-265006-m1dmgcd1	36	37	of	of	IN
cord-265006-m1dmgcd1	36	38	COVID-19	COVID-19	NNP
cord-265006-m1dmgcd1	36	39	:	:	:
cord-265006-m1dmgcd1	36	40	A	a	DT
cord-265006-m1dmgcd1	36	41	systematic	systematic	JJ
cord-265006-m1dmgcd1	36	42	review	review	NN
cord-265006-m1dmgcd1	36	43	and	and	CC
cord-265006-m1dmgcd1	36	44	meta	meta	NN
cord-265006-m1dmgcd1	36	45	-	-	HYPH
cord-265006-m1dmgcd1	36	46	analysis	analysis	NN
cord-265006-m1dmgcd1	36	47	Outcomes	outcome	NNS
cord-265006-m1dmgcd1	36	48	of	of	IN
cord-265006-m1dmgcd1	36	49	renin	renin	NN
cord-265006-m1dmgcd1	36	50	-	-	HYPH
cord-265006-m1dmgcd1	36	51	angiotensin	angiotensin	NN
cord-265006-m1dmgcd1	36	52	-	-	HYPH
cord-265006-m1dmgcd1	36	53	aldosterone	aldosterone	NN
cord-265006-m1dmgcd1	36	54	system	system	NN
cord-265006-m1dmgcd1	36	55	blockers	blocker	NNS
cord-265006-m1dmgcd1	36	56	in	in	IN
cord-265006-m1dmgcd1	36	57	patients	patient	NNS
cord-265006-m1dmgcd1	36	58	with	with	IN
cord-265006-m1dmgcd1	36	59	COVID-19	COVID-19	NNP
cord-265006-m1dmgcd1	36	60	:	:	:
cord-265006-m1dmgcd1	36	61	a	a	DT
cord-265006-m1dmgcd1	36	62	systematic	systematic	JJ
cord-265006-m1dmgcd1	36	63	review	review	NN
cord-265006-m1dmgcd1	36	64	and	and	CC
cord-265006-m1dmgcd1	36	65	meta	meta	NNP
cord-265006-m1dmgcd1	36	66	-	-	HYPH
cord-265006-m1dmgcd1	36	67	analysis	analysis	NN
cord-265006-m1dmgcd1	37	1	A	a	DT
cord-265006-m1dmgcd1	37	2	Meta	Meta	NNP
cord-265006-m1dmgcd1	37	3	-	-	HYPH
cord-265006-m1dmgcd1	37	4	analysis	analysis	NN
cord-265006-m1dmgcd1	37	5	of	of	IN
cord-265006-m1dmgcd1	37	6	the	the	DT
cord-265006-m1dmgcd1	37	7	Relationship	Relationship	NNP
cord-265006-m1dmgcd1	37	8	Between	between	IN
cord-265006-m1dmgcd1	37	9	Renin	Renin	NNP
cord-265006-m1dmgcd1	37	10	-	-	HYPH
cord-265006-m1dmgcd1	37	11	Angiotensin	Angiotensin	NNP
cord-265006-m1dmgcd1	37	12	-	-	HYPH
cord-265006-m1dmgcd1	37	13	Aldosterone	Aldosterone	NNP
cord-265006-m1dmgcd1	37	14	System	System	NNP
cord-265006-m1dmgcd1	37	15	Inhibitors	Inhibitors	NNP
cord-265006-m1dmgcd1	37	16	and	and	CC
cord-265006-m1dmgcd1	37	17	COVID-19	COVID-19	NNP
cord-265006-m1dmgcd1	38	1	The	the	DT
cord-265006-m1dmgcd1	38	2	use	use	NN
cord-265006-m1dmgcd1	38	3	of	of	IN
cord-265006-m1dmgcd1	38	4	renin	renin	NN
cord-265006-m1dmgcd1	38	5	angiotensin	angiotensin	NN
cord-265006-m1dmgcd1	38	6	system	system	NN
cord-265006-m1dmgcd1	38	7	inhibitor	inhibitor	NN
cord-265006-m1dmgcd1	38	8	on	on	IN
cord-265006-m1dmgcd1	38	9	mortality	mortality	NN
cord-265006-m1dmgcd1	38	10	in	in	IN
cord-265006-m1dmgcd1	38	11	patients	patient	NNS
cord-265006-m1dmgcd1	38	12	with	with	IN
cord-265006-m1dmgcd1	38	13	coronavirus	coronavirus	NN
cord-265006-m1dmgcd1	38	14	disease	disease	NN
cord-265006-m1dmgcd1	38	15	2019	2019	CD
cord-265006-m1dmgcd1	38	16	(	(	-LRB-
cord-265006-m1dmgcd1	38	17	COVID-19	COVID-19	NNP
cord-265006-m1dmgcd1	38	18	)	)	-RRB-
cord-265006-m1dmgcd1	38	19	:	:	:
cord-265006-m1dmgcd1	38	20	A	a	DT
cord-265006-m1dmgcd1	38	21	systematic	systematic	JJ
cord-265006-m1dmgcd1	38	22	review	review	NN
cord-265006-m1dmgcd1	38	23	and	and	CC
cord-265006-m1dmgcd1	38	24	meta	meta	NNP
cord-265006-m1dmgcd1	38	25	-	-	HYPH
cord-265006-m1dmgcd1	38	26	analysis	analysis	NN
cord-265006-m1dmgcd1	38	27	Cardiovascular	Cardiovascular	NNP
cord-265006-m1dmgcd1	38	28	Disease	Disease	NNP
cord-265006-m1dmgcd1	38	29	and	and	CC
cord-265006-m1dmgcd1	38	30	Use	Use	NNP
cord-265006-m1dmgcd1	38	31	of	of	IN
cord-265006-m1dmgcd1	38	32	Renin	Renin	NNP
cord-265006-m1dmgcd1	38	33	-	-	HYPH
cord-265006-m1dmgcd1	38	34	Angiotensin	Angiotensin	NNP
cord-265006-m1dmgcd1	38	35	System	System	NNP
cord-265006-m1dmgcd1	38	36	Inhibitors	Inhibitors	NNP
cord-265006-m1dmgcd1	38	37	in	in	IN
cord-265006-m1dmgcd1	38	38	COVID-19	COVID-19	NNP
cord-265006-m1dmgcd1	38	39	Association	Association	NNP
cord-265006-m1dmgcd1	38	40	between	between	IN
cord-265006-m1dmgcd1	38	41	renin	renin	NN
cord-265006-m1dmgcd1	38	42	-	-	HYPH
cord-265006-m1dmgcd1	38	43	angiotensin	angiotensin	NN
cord-265006-m1dmgcd1	38	44	system	system	NN
cord-265006-m1dmgcd1	38	45	inhibitors	inhibitor	NNS
cord-265006-m1dmgcd1	38	46	and	and	CC
cord-265006-m1dmgcd1	38	47	COVID-19	covid-19	JJ
cord-265006-m1dmgcd1	38	48	complications	complication	NNS